期刊文献+

水凝胶在青光眼缓控释递药中的研究进展 被引量:1

Research Progress on Hydrogel-based Sustained and Controlled Drug Delivery for Glaucoma
原文传递
导出
摘要 青光眼严重影响正常视觉功能,但目前药物治疗效率低下。眼部缓控释制剂可以延长药物作用时间,减少给药次数,提高患者顺应性。水凝胶是一类在眼科中用途极其广泛的材料,预制凝胶和原位凝胶在眼科药物的缓控释递送中显示出极大潜力。以接触镜为代表的预制凝胶则可提供持续的药物释放和眼前滞留。原位凝胶兼具溶液剂给药方便和凝胶剂延缓释药的优势。本文就近几年不同给药途径中将水凝胶应用于抗青光眼药物缓控释研究中的进展进行归纳和总结,并讨论水凝胶在青光眼的治疗中存在的挑战,希望能为其临床使用提供参考。 Glaucoma affects normal visual function seriously,but the efficiency of drug treatment is low.Sustained and controlled-release ophthalmic preparations can prolong the duration time of the drug,reduce the times of administrations,and improve patient compliance.Hydrogels are a class of materials that are extremely versatile in ophthalmology.Preformed gels and in situ gels show great potential for the sustained delivery of ophthalmic drugs.Preformed gels represented by contact lenses provide sustained drug release and prolonged drug duration time while in situ gels have the advantage of both ease of administration and delayed release of drugs.The research progress of sustained and controlled release gels in the delivery of anti-glaucoma drugs in recent years are summarized,the current challenges during research and application process are discussed,expected to provide the reference for its clinical application.
作者 姚晓长 陈锋 YAO Xiaochang;CHEN Feng(Xiangya Hospital,Central South University,Office of Clinical Drug Trial Administration,Changsha 410008,China;Xiangya Hospital,Central South University,Department of Pharmacy,Changsha 410008,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2022年第16期2165-2172,共8页 Chinese Journal of Modern Applied Pharmacy
关键词 水凝胶 青光眼 缓控释递药 接触镜 原位凝胶 hydrogel glaucoma sustained and controlled-release drug delivery contact lenses in situ gel
  • 相关文献

参考文献5

二级参考文献32

  • 1张士胜,张琼,王康孙.亚洲年龄相关性眼病流行病学调查概览[J].国际眼科杂志,2006,6(4):879-881. 被引量:19
  • 2Grunwold JE, Pihz J, Hariprasad SM, et al. Optic nerve and choroidal circulation in glaucoma. Invest Ophtbalmol Vis Sci 1998;39 (12) :23-29. 被引量:1
  • 3Monrrison JC, Nylander KB, Lauer AK, et al. Glaucoma drops control intraocular pressure and protect optic nerves in rat model of glaucoma. Invest Ophthalmol Vis Sci 1998 ;39(3) :526-531. 被引量:1
  • 4Schwartz M. Physiological approaches to neuroprotection boosting of protective autoimmuruty. Surv Ophthalmol 2001 ;45 ( 13 ) :256. 被引量:1
  • 5Gupta N, Yucel YH. Glaucoma and the brain. J Glaucoma 2001;10 ( 11 ) : 28-29. 被引量:1
  • 6Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reaction on retinae of rats with experimental glaucoma. Exp Brain Res 2000;132(4) :476-484. 被引量:1
  • 7Donello JF, Padillo EU, Webster ML, et al. Alpha(2)-adrenoceptor agomsts inhibit vitreal glutamate and aspartate accumlation and preserve retinal function after transtent rschemia.Pharmaacol Exp Ther 2001 ;296 (1):216. 被引量:1
  • 8Netland PA, LandryT, Sullivan EK, et al . Travoprost compared with latanoprostand timolol in patients with open-angle glaucorua orocular hypertension. Am J Ophthalmo 2001 ;132:472-484. 被引量:1
  • 9Toriu N, Akaike A, Yasuyoshi H, et al. Lomerizine, a Ca2 + channe blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000;70(3) :472-478. 被引量:1
  • 10Pang IH, Wexler EM, Nawy S, et al . Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells. Invest Ophthalmol Vis Sci 1999;40(6) :1170-1176. 被引量:1

共引文献39

同被引文献26

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部